Arkolith/Insider Trading/NMTR/Form 4

Temperato John

Chief Executive Officer, Director9 METERS BIOPHARMA, INC. (NMTR) · full profile →Form 4 · filed Mar 4, 2022
Net Buying
Open-Market Buys
$56K
Open-Market Sells
$0
Net Open-Market Flow
$56K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 3, 2022Buy(P)100K$0.56$56K1.3M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001551986-22-000021) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML